Abeona Therapeutics Inc vs American Electric Power Company Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while American Electric Power Company Inc trades at $123.61 (market cap $67.28B). The key difference: American Electric Power Company Inc is far larger — about 159.7× Abeona Therapeutics Inc's market cap, and American Electric Power Company Inc pays a 3.07% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | AEP | |
|---|---|---|
Market Cap | $421.19M | $67.28B |
Sector | Health | Utilities |
52-Week High | $7.45 | $138.69 |
52-Week Low | $4.17 | $106.44 |
Enterprise Value | $276.10M | $120.17B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →